STERIS PLC: FD Disclosure Regulation (Form 8-K)
Article 7.01 Regulation FD Disclosure
STERIS acquired the Renal Care activity as part of the Cantel Medical transaction concluded on
Evoqua Water Technologies is a leading provider of water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers.
CAUTION REGARDING FORWARD-LOOKING INFORMATION
This current report on Form 8-K may contain statements regarding certain trends, expectations, forecasts, estimates or other forward-looking information affecting or relating to STERIS or its industry, products or activities which are intended to benefit from the protections afforded ” forward forward-looking statements “under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as of the date on which the statement is made and can be identified by the use of forward-looking terms such that “may”, “will”, “expects”, “believes”, “anticipates”, “plans”, “” estimates “,” projects “,” targets “,” forecasts “,” outlook “,” impact “,” potential “,” confidence “,” improve “,” optimistic “,” deliver “,” orders “,” backlog “,” comfortable “,” trend “and” research “or the negative of these terms or d ” other variations on these terms or comparable terminology e. There are many important factors that could cause actual results to differ materially from forward-looking statements, including, without limitation, an interruption of production or supplies, changes in market conditions, political events, pending or future claims or litigation, competitive factors, technological advancements, actions of regulatory agencies, and changes in laws, government regulations, labeling or product or application approvals or interpretation of these. Other risk factors are described in other STERIS securities filings, including Item 1A of our annual report on Form 10-K for the year ended.
(“Redomiciliation”), (c) operating costs, losses of Customers and business disruptions (including, without limitation, difficulties in maintaining relationships with employees, Customers, customers or suppliers) being greater than expected as a result of the Redomiciliation, (d) the ability of STERIS to successfully integrate Cantel Medical’s business into our existing business, including unknown or invaluable liabilities, or increases in costs of expected integration or difficulties related to the integration of Cantel Medical, (e) the ability of STERIS to meet expectations regarding the accounting and tax treatment of the Tax Cuts and Jobs Act (“TCJA”) or the possibility that the expected benefits resulting from the TCJA are lower than estimated, (f) changes in tax laws or interpretations that could increase our consolidated tax obligations, including changes in tax laws that would result in that STERIS is treated as a national company for
Â© Edgar online, source